Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry

20 May 2025 (08:50 - 09:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Riccardo Maria Inciardi

Civil Hospital of Brescia, Brescia (Italy)

6 More presentations in this session

Presentation thumbnail

Discussant panel

Presentation thumbnail

Treatment uptake in the era of quadruple pharmacotherapy for heart failure with reduced ejection fraction: from prescriptions to patient adherence and persistence

Doctor F. Lindberg (Stockholm, SE)

Presentation thumbnail

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Doctor K. Berge (Nordbyhagen, NO)

Presentation thumbnail

Timing of cardiac resynchronization therapy after optimal medical therapy in patients with heart failure: temporal trends, predictors and association with outcomes

Doctor A. Villaschi (Milan, IT)

Presentation thumbnail

Cardiac resynchronization therapy in heart failure: a target trial emulation study

Doctor C. Basile (Stockholm, SE)

Access the full session

Session thumbnail

Latest registries and observational studies

The Event

Event poster

Heart Failure 2025

20 May 2025 08:50 CET

You may be interested in

Congress Presentation

Therapeutic implementation in patients with newly diagnosed heart failure: data from the italian multicenter registry OpTIMa-HF

Congress Session

Advances in heart failure detection and therapy

Congress Presentation

Real world medical therapy for heart failure with reduced and mildly reduced ejection fraction: REMEDI-HF study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources